Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8559363 | 0.89 | LMNA (0.68) | KMT2AMEN1LMNACYP3A4ACHE | |
| SCHEMBL8759992 | 0.87 | CYP1A2 (0.51) | KMT2AMEN1LMNACYP3A4ACHE | |
| SCHEMBL1405221 | 0.85 | ELANE (0.47) | KMT2A | |
| SCHEMBL3178391 | 0.79 | KMT2A (0.46) | KMT2AMEN1NPC1 | |
| SCHEMBL249305 | 0.78 | LMNA (0.76) | KMT2AMEN1LMNACYP3A4ACHE | |
| SCHEMBL17028900 | 0.78 | LMNA (0.76) | KMT2AMEN1LMNACYP3A4ACHE | |
| SCHEMBL17138182 | 0.78 | KMT2A (0.50) | KMT2AMEN1LMNACYP3A4ACHE | |
| SCHEMBL17138180 | 0.78 | KMT2A (0.50) | KMT2AMEN1LMNACYP3A4ACHE | |
| SCHEMBL3186605 | 0.77 | KDM4E (0.46) | KMT2ALMNAACHE | |
| SCHEMBL4781565 | 0.76 | MAPK1 (0.43) | KMT2AMEN1LMNAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | KMT2A 580/4885MEN1 4684/4885LMNA 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.